| Matthew Deren, MD | |
|
119 Belmont St, Worcester, MA 01605 | |
| (508) 334-9750 | |
| (508) 334-9762 |
| Full Name | Matthew Deren |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 119 Belmont St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043503279 | NPI | - | NPPES |
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Counselor Robert A. Moylan, LCPC has discovered through forty years of psychology research and life experience the simplest and most effective behavioral psychology approach currently available in the world to treat addictions, depression, anxiety, anger, trauma, and personality disorders. His book for adults, "Emotional Core Therapy" is currently the top rated book on Amazon.com in two different categories: "Mental Health" and "Emotions".
Fewer individuals across the globe would be diagnosed with post-traumatic stress disorder (PTSD) under proposed changes to the most widely used diagnostic tool – potentially impacting clinical practice, national data reporting and epidemiological research, according to an international analytical study led by NYU School of Medicine and publishing May 14 in the journal Psychological Medicine.
A recent study, conducted at the Gerontology Research Center of the University of Jyväskylä, shows that walk-friendly environmental design may provide opportunities for physical activity in old age.
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Deren, MD Po Box 415348, Boston, MA 02241-5348 Ph: () - | Matthew Deren, MD 119 Belmont St, Worcester, MA 01605 Ph: (508) 334-9750 |
News Archive
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Counselor Robert A. Moylan, LCPC has discovered through forty years of psychology research and life experience the simplest and most effective behavioral psychology approach currently available in the world to treat addictions, depression, anxiety, anger, trauma, and personality disorders. His book for adults, "Emotional Core Therapy" is currently the top rated book on Amazon.com in two different categories: "Mental Health" and "Emotions".
Fewer individuals across the globe would be diagnosed with post-traumatic stress disorder (PTSD) under proposed changes to the most widely used diagnostic tool – potentially impacting clinical practice, national data reporting and epidemiological research, according to an international analytical study led by NYU School of Medicine and publishing May 14 in the journal Psychological Medicine.
A recent study, conducted at the Gerontology Research Center of the University of Jyväskylä, shows that walk-friendly environmental design may provide opportunities for physical activity in old age.
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
› Verified 8 days ago
Wayne Wayfu Chan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-9750 Fax: 508-334-9762 | |
Thomas J Kesman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Ste 320, Worcester, MA 01608 Phone: 508-368-3140 Fax: 508-368-3143 | |
Christina G Kane, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Dr. Mary Ann Badon, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave North, Worcester, MA 01655 Phone: 508-334-1000 | |
Christopher Jay Vinton, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 59 Quinsigamond Ave, Worcester County Orthopedics, Worcester, MA 01610 Phone: 508-755-1123 Fax: 508-755-5640 | |
Brian Burroughs, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St Ste 320, Worcester, MA 01608 Phone: 508-964-5580 Fax: 508-368-3143 |